Publications by authors named "Ari W Schaler"

During aging, microglia produce inflammatory factors, show reduced tissue surveillance, altered interactions with synapses, and prolonged responses to CNS insults, positioning these cells to have profound impact on the function of nearby neurons. We and others recently showed that microglial attributes differ significantly across brain regions in young adult mice. However, the degree to which microglial properties vary during aging is largely unexplored.

View Article and Find Full Text PDF
Article Synopsis
  • - In Alzheimer's disease and related tauopathies, the transfer and buildup of pathological tau from one neuron to another play a crucial role in worsening the disease, but the exact processes involved are still unclear.
  • - Researchers used both in vivo and in vitro models to investigate how defective protein clearance, indicated by the accumulation of a marker called p62, relates to the spread of tau pathology, finding that p62 and human tau often appeared together in affected brain regions.
  • - The study suggests that the buildup of pathological tau disrupts the mechanisms responsible for clearing proteins, creating a cycle that leads to increased tau accumulation and worsens disease progression in neurons over time.
View Article and Find Full Text PDF

Accumulation of pathological tau in synapses has been identified as an early event in Alzheimer's disease (AD) and correlates with cognitive decline in patients with AD. Tau is a cytosolic axonal protein, but under disease conditions, tau accumulates in postsynaptic compartments and presynaptic terminals, due to missorting within neurons, transsynaptic transfer between neurons, or a failure of clearance pathways. Using subcellular fractionation of brain tissue from rTg4510 tau transgenic mice with tauopathy and human postmortem brain tissue from patients with AD, we found accumulation of seed-competent tau predominantly in postsynaptic compartments.

View Article and Find Full Text PDF

The cognitive symptoms of schizophrenia are poorly understood and difficult to treat. Estrogens may mitigate these symptoms via unknown mechanisms. To examine these mechanisms, we tested whether increasing estradiol (E) or decreasing luteinizing hormone (LH) could mitigate short-term episodic memory loss in a phencyclidine (PCP) model of schizophrenia.

View Article and Find Full Text PDF

Alzheimer's disease and several variants of frontotemporal degeneration including progressive supranuclear palsy and corticobasal degeneration are characterized by the accumulation of abnormal tau protein into aggregates. Most proteins, including tau, are degraded via the ubiquitin proteasome system, but when abnormal tau accumulates, the function of 26S proteasomes is downregulated. The negative effect of tau aggregates on the function of the proteasome can have deleterious consequences on protein homeostasis and disease progression.

View Article and Find Full Text PDF